IMPAVIDO NOW AVAILABLE IN THE USA
Impavido (miltefosine) is now available in the USA directly from Profounda for the treatment of leishmania.
Profounda takes on Leishmaniasis
Profounda licenses Impavido from Knight Therapeutics for marketing into the US. Leishmaniasis is a parasitic disease that is found in...
Knight Profounda U.S. Partner for Impavido
MONTREAL, Canada, September 25, 2015 – Knight Therapeutics Inc. (TSX: GUD) (“Knight”), through one of its wholly-owned subsidiaries,...
Profounda to attend CCA Meeting In Orlando on August 6/7th 2015
Profounda will be introducing Rhinase Soothing Nasal Mist and Lubricating Nasal Gel at the Convenient Care Association Meeting held in...
Fall Relief to Allergies on its way
Profounda Plans to launch Rhinase in Fall 2015 Profounda Inc. (private) today announced the pre-market preparation for the planned launch...
Profounda licenses 2 OTC products for US market
Profounda Inc. (private) today announced the signing of a license agreement with a major pharmaceutical company for a line of OTC...